Amgen Told to Reword Drug Label
Thursday, July 31, 2008 - 19:07
in Health & Medicine
The Food and Drug Administration has ordered Amgen to change the labels for its flagship anemia drugs in a way that could further restrict their use in treating patients with cancer.